Microbiology Testing Market worth $10.09 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 12, 2026 /PRNewswire/ — According to MarketsandMarkets, the Microbiology Testing Market is projected to grow from about USD 7.79 billion in 2026 to USD 10.09 billion by 2031, at a CAGR of 5.3%.

Browse 246 market data tables and 51 figures spread through 379 pages and an in-depth TOC on the “Microbiology testing market – Global Forecast to 2031”

Microbiology Testing Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 7.79 billion
• 2031 Projected Market Size: USD 10.09 billion
• CAGR (2026–2031): 5.3%

Microbiology Testing Market Trends & Insights:

• The Traditional Microbiology Methods (TMM) accounted for the largest market share in 2025 with 63.0% of the shares.
• The Pharmaceutical & Biotech Companies segment is registered to have the fastest growth in the forecasted period of 5.7%.
• The North America region accounted for the largest market share in 2025 with 38.6% of the shares.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187005691 

Microbiology testing is widely used across pharmaceutical manufacturing, biotechnology, food and beverage processing, water quality monitoring, and environmental applications. Market expansion is driven by rising demand for contamination detection, stringent quality and regulatory requirements, and the scaling of industrial production. Key trends in the microbiology testing market include the growing adoption of rapid and automated testing technologies, increased use of standardized reagents and kits, and a stronger focus on quality assurance, safety, and risk mitigation across end-use industries. 

The market for microbiology testing is growing steadily due to several key factors, including rising focus on contamination control, product quality, and regulatory compliance across various industrial and manufacturing sectors. As production scales and quality assurance measures improve, the need for precise and reliable microbial testing has also increased. Improvements in testing technology, such as advances in culture-based testing and the rising adoption of rapid testing technologies, have improved testing speed, sensitivity, and turnaround times. In addition, the development of standardized, ready-to-use reagents and kits has created new opportunities by streamlining processes, improving consistency, and helping manage operational costs. However, the current high cost of advanced testing systems is a significant hindrance, especially in smaller facilities with budget constraints.

By product, the reagents & kits segment is expected to grow at the fastest rate during the forecast period.

The microbiology testing market is divided into three main segments based on product: instruments, reagents & kits, and consumables. Due to their frequent use, broad applicability across routine and specialized testing, and crucial role in sample preparation, microbial detection, and identification, reagents and kits comprise the largest share of the microbiology testing market. Reagents and kits are used continuously throughout testing workflows, creating steady demand, unlike equipment, which is a capital purchase. They are used for contamination monitoring, quality control, and regulatory compliance in pharmaceuticals, biotechnology, food, water, and environmental testing. Furthermore, the growing use of standardized, ready-to-use kits enhances testing accuracy, reduces operator reliance, and facilitates quicker turnaround times, all of which contribute to this segment’s supremacy.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=187005691

By end user, the pharmaceutical & biotech companies segment is expected to hold the largest share during the forecast period.

the microbiology testing market is divided into pharmaceutical & biotech companies, food & beverage companies, environmental & water testing, cosmetic & personal-care companies, and other end users. Among these end users, pharmaceutical & biotech companies held the largest market share in 2025 for microbiology testing. Pharmaceutical and biotechnology companies represent the largest end user segment in the microbiology testing market due to their strict regulatory requirements, high sensitivity to contamination risks, and continuous need for quality assurance across manufacturing and research processes. Microbial testing is essential at multiple stages, including raw material validation, in-process monitoring, finished product release, and stability testing, driving high testing volumes.

North America is projected to hold the major share of the global microbiology testing market during the forecast period.

The microbiology testing market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the largest market share in the microbiology testing market in 2025, driven by its robust regulatory framework, sophisticated industrial infrastructure, and widespread acceptance of quality and safety standards across the pharmaceutical, biotechnology, food, water, and environmental sectors. The steady demand for microbiological analysis is driven by numerous international manufacturers, research centers, and testing labs. Additionally, market expansion is supported by the early adoption of cutting-edge and rapid testing technologies, together with substantial R&D expenditures.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=187005691

Top Companies in Microbiology Testing Market:

The Top Companies in Microbiology Testing Market include BIOMÉRIEUX (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (BD) (US), Charles River Laboratories (US), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Bruker (US), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), and IDEXX (US).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Nucleic Acid Isolation and Purification Market – Global Forecast to 2030

Rapid Microbiology Testing Market – Global Forecast to 2029

Clinical Microbiology Market – Global Forecast to 2030               

Preimplantation Genetic Testing Market – Global Forecast to 2030

Molecular Infectious Disease Testing Market – Global Forecast to 2029

About MarketsandMarkets 

MarketsandMarkets has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/microbiology-testing-market-worth-10-09-billion-by-2031–marketsandmarkets-302685966.html

SOURCE MarketsandMarkets